Medvi vs HealthRx vs DirectMeds: Support, Speed, Simplicity
Last updated: Sep 1, 2026
Medical reviewer: Francheska Capistrano, RMT, MPH · Medical Content Reviewer
Reviews this site’s health content for scientific accuracy · Written by Treatments Hub Research Team · How we review
We may earn a commission from links on this page - it never affects our rankings (how we stay objective).
Here’s the short version
Three providers, three completely different bets. Medvi bets on people: video visits, dietician, coaching, and 14,987 Trustpilot reviews averaging 4.3. HealthRx bets on logistics: $99/month semaglutide (12-month prepaid, $1,188 at checkout) with overnight cold-chain delivery. DirectMeds bets on simplicity: one flat $147 for either medication, injections or needle-free sublingual drops, no membership. The matrix below puts the three bets side by side.
GLP-1 program from $99/month - clinician consult to overnight delivery
Visit HealthRx
Medvi vs HealthRx vs DirectMeds: side by side
Real published prices and terms - the differences that actually decide this matchup.
| Medvi | HealthRx | DirectMeds | |
|---|---|---|---|
| Semaglutide | $99/mo promo (reg. $199), all-inclusive | $99/mo on a 12-month prepaid plan ($1,188 at checkout) | $147/mo, flat at every dose |
| Tirzepatide | $166/mo promo (reg. $299) | from $179/mo | $147/mo - same flat price |
| Billing & commitment | Monthly, all-inclusive - no surprise charges; HSA/FSA approved | 12-month prepaid - full year due at checkout | Monthly - no membership, cancel anytime |
| Shipping | Free shipping | Free overnight cold-chain, lot-tracked | Free 1-2 day shipping |
| Support | Video visits + free dietician & care coaching | Care-team check-ins; clinician review on every request | Doctor-prescribed; injections or needle-free drops |
| Guarantee / refund | - | Free assessment - no payment to start | - |
| Standout | 4.3 on Trustpilot across 14,987 reviews | LegitScript-certified (cert. 50087439); 503A pharmacies | Only needle-free sublingual option in our ranking |
Our verdict
Choose the bet that matches your bottleneck. If support determines your success, Medvi - its review record is the strongest evidence in this trio. If you've committed to a year and want the sharpest committed price with premium delivery, HealthRx. If you want one predictable number forever - or you need the needle-free format nobody else offers - DirectMeds. All three run licensed clinical review; none is a legitimacy risk.
Medvi vs HealthRx vs DirectMeds: FAQs
Which is cheapest: Medvi, HealthRx or DirectMeds?
For semaglutide, Medvi and HealthRx both work out to $99/month - but the structures differ: Medvi's is a monthly promotional rate (regularly $199) with no prepay, while HealthRx's is a 12-month prepaid plan with $1,188 due at checkout. DirectMeds charges a flat $147/month. For tirzepatide, DirectMeds' flat $147 leads, with Medvi at $166 promotional (regularly $299) and HealthRx from $179.
Which one has a needle-free option?
Only DirectMeds - it offers compounded GLP-1 as sublingual oral drops as well as weekly injections, at the same $147/month price. The prescribing doctor decides with you whether the drops format is appropriate.
Which delivers fastest?
HealthRx ships overnight in temperature-controlled, lot-tracked packaging - free on every plan. DirectMeds ships free in 1-2 days. Medvi includes free shipping on standard timelines.
Sources & medical references
Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.
- 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
- 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
- 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
- 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
- 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
- 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
- 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)